BioLife Solutions customer reports positive data By: MarketMinute.com Stock News August 31, 2015 at 14:03 PM EDT BioLife Solutions Inc. (Nasdaq: BLFS) customer TiGenix reported positive Phase III ADMIRE-CD trial results for Cx601. Shares of BioLife gained 81 cents to $2.85. Related Stocks: Biolife Solutions